Cargando…

Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya

BACKGROUND: The contraceptive vaginal ring (NuvaRing), one of the Multipurpose Prevention Technologies (MPT) products, is effective in preventing unintended pregnancies and may contribute to reducing the frequency of Bacterial Vaginosis (BV), which is a risk factor for HIV acquisition, transmission,...

Descripción completa

Detalles Bibliográficos
Autores principales: Casmir, Edinah, Wairimu, Njeri, Kiptinness, Catherine, Oluoch, Lynda, Maina, Stephen Gakuo, Walker, Kristina Wilbekin, Mugo, Nelly, Marrazzo, Jeanne, Ngure, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371177/
https://www.ncbi.nlm.nih.gov/pubmed/37503186
http://dx.doi.org/10.1101/2023.07.14.23292684
_version_ 1785078099548831744
author Casmir, Edinah
Wairimu, Njeri
Kiptinness, Catherine
Oluoch, Lynda
Maina, Stephen Gakuo
Walker, Kristina Wilbekin
Mugo, Nelly
Marrazzo, Jeanne
Ngure, Kenneth
author_facet Casmir, Edinah
Wairimu, Njeri
Kiptinness, Catherine
Oluoch, Lynda
Maina, Stephen Gakuo
Walker, Kristina Wilbekin
Mugo, Nelly
Marrazzo, Jeanne
Ngure, Kenneth
author_sort Casmir, Edinah
collection PubMed
description BACKGROUND: The contraceptive vaginal ring (NuvaRing), one of the Multipurpose Prevention Technologies (MPT) products, is effective in preventing unintended pregnancies and may contribute to reducing the frequency of Bacterial Vaginosis (BV), which is a risk factor for HIV acquisition, transmission, and shedding among women. NuvaRing may cause irregular menstruation, including menstrual suppression, which may influence women’s decision on product choice, use, and acceptability. In this prospective cohort study, we assessed women’s experiences with menstruation suppression following continued NuvaRing use. METHODS: A total of 18 in-depth interviews were conducted using a semi-structured interview guide among purposively selected women with BV in Thika, Kenya, aged 18–40 years, who used NuvaRing continuously. All women received counseling on possibility of menstrual suppression following continuous NuvaRing use. Audio recordings were transcribed verbatim and thematically analyzed. RESULTS: Participants who expected and were aware that menstrual suppression was a possible side effect of Nuvaring accepted its benefits, and expressed acceptance and desire to continue using NuvaRing. Participants who had not anticipated menstrual suppression expressed anxiety and fear, with some expressing desire to continue using NuvaRing but worried about unintended negative consequences. The ability to perform daily activities uninterrupted, reduced expenses on sanitary supplies, enhanced sexual pleasure and relationships, and absence of menstrual pain were benefits of menstrual suppression. Although all participants received counseling on menstrual suppression, some expressed anxiety over the possibility of unintended pregnancy. As a result, they frequented medical facilities for health check-ups and pregnancy tests, and some used combined oral contraceptives to induce menses. CONCLUSION: Understanding perceptions regarding menstrual suppression is crucial in offering targeted and comprehensive counseling to improve women’s understanding of menstruation suppression to influence acceptance and use of NuvaRing. Additionally, improved male involvement in reproductive health concerns and women’s autonomy in discussing reproductive health issues with partners is essential.
format Online
Article
Text
id pubmed-10371177
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-103711772023-07-27 Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya Casmir, Edinah Wairimu, Njeri Kiptinness, Catherine Oluoch, Lynda Maina, Stephen Gakuo Walker, Kristina Wilbekin Mugo, Nelly Marrazzo, Jeanne Ngure, Kenneth medRxiv Article BACKGROUND: The contraceptive vaginal ring (NuvaRing), one of the Multipurpose Prevention Technologies (MPT) products, is effective in preventing unintended pregnancies and may contribute to reducing the frequency of Bacterial Vaginosis (BV), which is a risk factor for HIV acquisition, transmission, and shedding among women. NuvaRing may cause irregular menstruation, including menstrual suppression, which may influence women’s decision on product choice, use, and acceptability. In this prospective cohort study, we assessed women’s experiences with menstruation suppression following continued NuvaRing use. METHODS: A total of 18 in-depth interviews were conducted using a semi-structured interview guide among purposively selected women with BV in Thika, Kenya, aged 18–40 years, who used NuvaRing continuously. All women received counseling on possibility of menstrual suppression following continuous NuvaRing use. Audio recordings were transcribed verbatim and thematically analyzed. RESULTS: Participants who expected and were aware that menstrual suppression was a possible side effect of Nuvaring accepted its benefits, and expressed acceptance and desire to continue using NuvaRing. Participants who had not anticipated menstrual suppression expressed anxiety and fear, with some expressing desire to continue using NuvaRing but worried about unintended negative consequences. The ability to perform daily activities uninterrupted, reduced expenses on sanitary supplies, enhanced sexual pleasure and relationships, and absence of menstrual pain were benefits of menstrual suppression. Although all participants received counseling on menstrual suppression, some expressed anxiety over the possibility of unintended pregnancy. As a result, they frequented medical facilities for health check-ups and pregnancy tests, and some used combined oral contraceptives to induce menses. CONCLUSION: Understanding perceptions regarding menstrual suppression is crucial in offering targeted and comprehensive counseling to improve women’s understanding of menstruation suppression to influence acceptance and use of NuvaRing. Additionally, improved male involvement in reproductive health concerns and women’s autonomy in discussing reproductive health issues with partners is essential. Cold Spring Harbor Laboratory 2023-07-16 /pmc/articles/PMC10371177/ /pubmed/37503186 http://dx.doi.org/10.1101/2023.07.14.23292684 Text en This article is a US Government work.
spellingShingle Article
Casmir, Edinah
Wairimu, Njeri
Kiptinness, Catherine
Oluoch, Lynda
Maina, Stephen Gakuo
Walker, Kristina Wilbekin
Mugo, Nelly
Marrazzo, Jeanne
Ngure, Kenneth
Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya
title Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya
title_full Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya
title_fullStr Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya
title_full_unstemmed Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya
title_short Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya
title_sort experiences and attitudes towards menstrual suppression among women with bacterial vaginosis randomised to continuous use of nuvaring in kenya
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371177/
https://www.ncbi.nlm.nih.gov/pubmed/37503186
http://dx.doi.org/10.1101/2023.07.14.23292684
work_keys_str_mv AT casmiredinah experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya
AT wairimunjeri experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya
AT kiptinnesscatherine experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya
AT oluochlynda experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya
AT mainastephengakuo experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya
AT walkerkristinawilbekin experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya
AT mugonelly experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya
AT marrazzojeanne experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya
AT ngurekenneth experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya